MediClin AG: The Company strategy of MediClin is a model of success
DGAP-News: MediClin AG / Key word(s): AGM/EGM
MediClin AG: The Company strategy of MediClin is a model of success
24.05.2012 / 13:40
---------------------------------------------------------------------
Offenburg, May 23, 2012 - In his speech delivered at today's annual general
meeting of MEDICLIN Aktiengesellschaft in Frankfurt, Frank Abele, CEO, has
underlined, that MediClin will adhere to the present strategy of the
Company. 'We offer an integrated medical care, cross-sectors, close to
patients' homes with high medical quality and the results of our treatments
and therapies are disclosed to everybody in a transparent and public way in
our quality reports,' he said and added; 'We have our emphasis on specific
medical fields which are growth areas due to demographic and
civilisation-related developments and we will again invest in internal
growth by increasing our capacity and to make use of cost reduction
potentials.'
Good start in the new financial year
In the first three months of the new financial year, MediClin achieved
sales of EUR 125.4 mill. which is EUR 5.4 mill. or 4.5 % above the
comparative period of the previous year. The Group operating result for the
first quarter of 2012 was EUR -1.2 mill. Adjusted by an aperiodic release
of provisions for budget risks in the amount of EUR 1.1 mill., which was
included in the previous year's figure, the Group operating result was EUR
0.5 mill. higher than the figure achieved in the previous year. Clearly
improved has the financial result due to a refinancing of the loans of the
insurance companies. This effect also let to an overall result on previous
year's level of EUR -2.0 mill.
Cooperation with Asklepios is well on track
An analysis of the common potentials available between MediClin and
Asklepios has started at Group level, as well as discussions about
location-specific cooperation between the facilities of both holding
companies.
MediClin expects that there will be additional growth potential in this
area because there are only a few locations where the range of services
offered by both groups overlap. Overall, the Management Board expects an
increase in sales in the current financial year and a solid development of
results, insofar as the framework conditions in the industry and the
referral behaviour of the coverage providers do not seriously change in
2012.
The annual general meeting of MediClin agreed to the proposed nominations
to the supervisory board. It confirmed the appointment by court order of
Stephan Leonhard, it re-elected Dr. Jochen Messemer and it nominated Dr.
Ulrich Wandschneider to be a member of the supervisory board, effective
June 1st, 2012. Furthermore the supervisory board proposed Dr. Ulrich
Wandschneider to become chairman of the supervisory board as soon as he
assumes is mandate.
At the annual meeting almost 89 per cent of MediClin's share capital was
represented. All items on the agenda which are subject to voting were
passed by 99.99% except one item which was passed by 99.45%.
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungs-zentren (medical care units) in 11 federal states MediClin has
a total capacity of approximately 8,100 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,300 employees.
End of Corporate News
---------------------------------------------------------------------
24.05.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
171375 24.05.2012
DGAP-News: MediClin AG / Key word(s): AGM/EGM
MediClin AG: The Company strategy of MediClin is a model of success
24.05.2012 / 13:40
---------------------------------------------------------------------
Offenburg, May 23, 2012 - In his speech delivered at today's annual general
meeting of MEDICLIN Aktiengesellschaft in Frankfurt, Frank Abele, CEO, has
underlined, that MediClin will adhere to the present strategy of the
Company. 'We offer an integrated medical care, cross-sectors, close to
patients' homes with high medical quality and the results of our treatments
and therapies are disclosed to everybody in a transparent and public way in
our quality reports,' he said and added; 'We have our emphasis on specific
medical fields which are growth areas due to demographic and
civilisation-related developments and we will again invest in internal
growth by increasing our capacity and to make use of cost reduction
potentials.'
Good start in the new financial year
In the first three months of the new financial year, MediClin achieved
sales of EUR 125.4 mill. which is EUR 5.4 mill. or 4.5 % above the
comparative period of the previous year. The Group operating result for the
first quarter of 2012 was EUR -1.2 mill. Adjusted by an aperiodic release
of provisions for budget risks in the amount of EUR 1.1 mill., which was
included in the previous year's figure, the Group operating result was EUR
0.5 mill. higher than the figure achieved in the previous year. Clearly
improved has the financial result due to a refinancing of the loans of the
insurance companies. This effect also let to an overall result on previous
year's level of EUR -2.0 mill.
Cooperation with Asklepios is well on track
An analysis of the common potentials available between MediClin and
Asklepios has started at Group level, as well as discussions about
location-specific cooperation between the facilities of both holding
companies.
MediClin expects that there will be additional growth potential in this
area because there are only a few locations where the range of services
offered by both groups overlap. Overall, the Management Board expects an
increase in sales in the current financial year and a solid development of
results, insofar as the framework conditions in the industry and the
referral behaviour of the coverage providers do not seriously change in
2012.
The annual general meeting of MediClin agreed to the proposed nominations
to the supervisory board. It confirmed the appointment by court order of
Stephan Leonhard, it re-elected Dr. Jochen Messemer and it nominated Dr.
Ulrich Wandschneider to be a member of the supervisory board, effective
June 1st, 2012. Furthermore the supervisory board proposed Dr. Ulrich
Wandschneider to become chairman of the supervisory board as soon as he
assumes is mandate.
At the annual meeting almost 89 per cent of MediClin's share capital was
represented. All items on the agenda which are subject to voting were
passed by 99.99% except one item which was passed by 99.45%.
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungs-zentren (medical care units) in 11 federal states MediClin has
a total capacity of approximately 8,100 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,300 employees.
End of Corporate News
---------------------------------------------------------------------
24.05.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
171375 24.05.2012